SciTech Development 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fenretinide nanoparticle (ST-001 nanoFenretinide) / SciTech Development
ST-001-010, NCT04234048: Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Recruiting
1
46
US
Fenretinide, nanoFenretinide, ST-001, 4-HPR, N-(4-hydroxyphenyl)retinamide, N-(4-hydroxyphenyl)-all-trans-retinamide
SciTech Development, Inc., Rush University Medical Center
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma, Peripheral T-Cell Lymphoma, Not Classified, Primary Cutaneous T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, Cutaneous T-cell Lymphoma, Follicular T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Sézary's Disease, Mycosis Fungoides
05/25
11/25
NCT06922539: ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Not yet recruiting
1
44
NA
Fenretinide, ST-001
SciTech Development, Inc.
Small Cell Lung Cancer
01/27
06/28
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fenretinide nanoparticle (ST-001 nanoFenretinide) / SciTech Development
ST-001-010, NCT04234048: Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Recruiting
1
46
US
Fenretinide, nanoFenretinide, ST-001, 4-HPR, N-(4-hydroxyphenyl)retinamide, N-(4-hydroxyphenyl)-all-trans-retinamide
SciTech Development, Inc., Rush University Medical Center
T-cell Lymphoma, Cutaneous/Peripheral T-Cell Lymphoma, Peripheral T-cell Lymphoma, Peripheral T-Cell Lymphoma, Not Classified, Primary Cutaneous T-cell Lymphoma, Cutaneous T-Cell Lymphoma, Unspecified, Cutaneous T-cell Lymphoma, Follicular T-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Sézary's Disease, Mycosis Fungoides
05/25
11/25
NCT06922539: ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Not yet recruiting
1
44
NA
Fenretinide, ST-001
SciTech Development, Inc.
Small Cell Lung Cancer
01/27
06/28

Download Options